BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8289484)

  • 1. Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis.
    Furukawa T; Koike T; Ying W; Kishi K; Aoki S; Gotoh T; Hashimoto S; Saitoh H; Hanano M; Shinada S
    Leukemia; 1994 Jan; 8(1):171-80. PubMed ID: 8289484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
    Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
    Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.
    Tange T; Nakahara K; Mitani K; Yamasaki I; Yasuda H; Tanaka F; Mizuguchi M; Oda H; Yatomi Y; Takanashi R
    Cancer Res; 1988 Nov; 48(21):6137-44. PubMed ID: 3167860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
    Hirata J; Sato H; Takahira H; Shiokawa S; Endo T; Nishimura J; Katsuno M; Masuda S; Sasaki R; Fukumaki Y
    Leukemia; 1990 May; 4(5):365-72. PubMed ID: 2167410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.
    Beran M; Pisa P; O'Brien S; Kurzrock R; Siciliano M; Cork A; Andersson BS; Kohli V; Kantarjian H
    Cancer Res; 1993 Aug; 53(15):3603-10. PubMed ID: 8339266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro].
    Utsunomiya Y; Iwamasa K; Yasukawa M; Tamai T; Shiosaka T; Bando S
    Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A granulocytic population with rearranged immunogenotype in chronic myelocytic leukemia blast crisis and Philadelphia-chromosome-positive acute leukemia with cross-lineage nature.
    Kita K; Shimizu N; Miwa H; Ikeda T; Nishii K; Morita N; Uchida T; Shirakawa S; Tsutani H; Nasu K
    Leukemia; 1993 Feb; 7(2):251-7. PubMed ID: 8381195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of GATA-1 mRNA in human myeloid leukemic cells.
    Guerrasio A; Saglio G; Rosso C; Alfarano A; Camaschella C; Lo Coco F; Biondi A; Rambaldi A; Nicolis S; Ottolenghi S
    Leukemia; 1994 Jun; 8(6):1034-8. PubMed ID: 8207977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
    Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
    Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein.
    Watanabe T; Kataoka T; Mizuta S; Kobayashi M; Uchida T; Imai K; Wada H; Kinoshita T; Murate T; Mizutani S
    Leukemia; 1995 Nov; 9(11):1926-34. PubMed ID: 7475285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis.
    Asou H; Eguchi M; Suzukawa K; Morishita K; Tanaka K; Date M; Hamamoto K; Kamada N
    Br J Haematol; 1996 Apr; 93(1):68-74. PubMed ID: 8611478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis.
    Russell M; Thompson F; Spier C; Taetle R
    Leukemia; 1993 Oct; 7(10):1654-7. PubMed ID: 8412328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia.
    Ohyashiki K; Ohyashiki JH; Fujieda H; Shimamoto T; Kawakubo K; Nakazawa S; Suzukawa K; Morishita K; Toyama K
    Leukemia; 1994 Dec; 8(12):2169-73. PubMed ID: 7808006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of a new erythroblastic leukemia cell line, EEB: phosphatidylglucoside-mediated erythroid differentiation and apoptosis.
    Kawano-Yamamoto C; Muroi K; Nagatsuka Y; Higuchi M; Kikuchi S; Nagai T; Hakomori SI; Ozawa K
    Leuk Res; 2006 Jul; 30(7):829-39. PubMed ID: 16332389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute erythroblastic leukemia presenting as FAB M6 with surface marker positive for megakaryocytic and erythroid: report of a case].
    Ohata M; Sugiura K; Otsuka S; Nonaka K; Nakazawa M
    Rinsho Ketsueki; 1994 Feb; 35(2):127-34. PubMed ID: 8139110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of leukemic blasts in peripheral blood specimens by reverse transcriptase polymerase chain reaction assay for myeloperoxidase mRNA.
    Zhang W; Austin GE; Farhi DC; Zaki SR
    Diagn Mol Pathol; 1993 Dec; 2(4):283-9. PubMed ID: 8118606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
    Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
    Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
    Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.